4:28 PM
 | 
Jan 24, 2012
 |  BC Extra  |  Company News

FDA approves new Genzyme plant for Fabrazyme

Genzyme Corp. said FDA approved its Framingham, Mass., manufacturing facility for the production of Fabry's disease therapy Fabrazyme agalsidase beta. FDA's approval follows EMA's...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >